230
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Maternal serum irisin levels in early and late-onset pre-eclamptic and healthy pregnancies

, , , ORCID Icon, , & show all
Pages 642-646 | Received 26 Jul 2017, Accepted 09 Sep 2017, Published online: 12 Feb 2018

References

  • Abdel-Hady ES, Fawzy M, El-Negri M, Nezar M, Ragab A, Helal AS. 2010. Is expectant management of early-onset severe preeclampsia worthwhile in low-resource settings? Archives of Gynecology and Obstetrics 282:23–27.
  • ACOG Practice Bulletin. 2002. Diagnosis and management of preeclampsia and eclampsia. Number 33. Obstetrics & Gynecology 99: 159–167.
  • Aydin S, Kuloglu T, Aydin S, Kalayci M, Yilmaz M, Cakmak T, et al. 2014. A comprehensive immunohistochemical examination of the distribution of the fat-burning protein irisin in biological tissues. Peptides 61:130–136.
  • Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, et al. 2012. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481:463–468.
  • Dong J, Dong Y, Dong Y, Chen F, Mitch WE, Zhang L. 2015. Inhibition of myostatin in mice improves insulin sensitivity via irisin-mediated cross talk between muscle and adipose tissues. International Journal of Obesity 40:434–442.
  • Du X, Jiang WX, Lv ZT. 2016. Lower circulating irisin level in patients with diabetes mellitus: a systematic review and meta-analysis. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones et Metabolisme 48:644–652.
  • Garces MF, Peralta JJ, Ruiz-Linares CE, Lozano AR, Poveda NE, Torres-Sierra AL, et al. 2014. Irisin levels during pregnancy and changes associated with the development of preeclampsia. The Journal of Clinical Endocrinology and Metabolism 99:2113–2119.
  • Hauguel-de Mouzon S, Guerre-Millo M. 2006. The placenta cytokine network and inflammatory signals. Placenta 27:794–798.
  • Hou N, Han F, Sun X. 2015. The relationship between circulating irisin levels and endothelial function in lean and obese subjects. Clinical Endocrinology 83:339–343.
  • Jiang M, Wan F, Wang F, Wu Q. 2015. Irisin relaxes mouse mesenteric arteries through endothelium-dependent and endothelium-independent mechanisms. Biochemical and Biophysical Research Communications 468:832–836.
  • Lain KY, Catalano PM. 2006. Factors that affect maternal insulin resistance and modify fetal growth and body composition. Metabolic Syndrome and Related Disorders 4:91–100.
  • Madazli R, Yuksel MA, Imamoglu M, Tuten A, Oncul M, Aydin B, et al. 2014. Comparison of clinical and perinatal outcomes in early- and late-onset preeclampsia. Archives of Gynecology and Obstetrics 290:53–57.
  • Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F, et al. 2013. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. The Journal of Clinical Endocrinology & Metabolism 98:769–778.
  • Nelson DB, Ziadie MS, McIntire DD, Rogers BB, Leveno KJ. 2014. Placental pathology suggesting that preeclampsia is more than one disease. American Journal of Obstetrics & Gynecology 210:661–667.
  • Park MJ, Kim DI, Choi JH, Heo YR, Park SH. 2015. New role of irisin in hepatocytes: the protective effect of hepatic steatosis in vitro. Cellular Signalling 27: 1831–1839.
  • Pedersen BK, Febbraio MA. 2012. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nature Reviews. Endocrinology 8:457–465.
  • Raymond D, Peterson E. 2011. A critical review of early-onset and late-onset preeclampsia. Obstetrical & Gynecological Survey 66: 497–506.
  • Roberts JM, Lain KY. 2002. Recent insights into the pathogenesis of pre-eclampsia. Placenta 23:359–372.
  • Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. 2010. Pre-eclampsia. The Lancet (London, England) 376:631–644.
  • Toescu V, Nuttall SL, Martin U, Kendall MJ, Dunne F. 2002. Oxidative stress and normal pregnancy. Clinical Endocrinology 57: 609–613.
  • Xiang L, Xiang G, Yue L, Zhang J, Zhao L. 2014. Circulating irisin levels are positively associated with endothelium-dependent vasodilation in newly diagnosed type 2 diabetic patients without clinical angiopathy. Atherosclerosis 235:328–333.
  • Yuksel MA, Oncul M, Tuten A, Imamoglu M, Acikgoz AS, Kucur M, et al. 2014. Maternal serum and fetal cord blood irisin levels in gestational diabetes mellitus. Diabetes Research Clinical Practice 104:171–175.
  • Zhang C, Ding Z, Lv G, Li J, Zhou P, Zhang J. 2016. Lower irisin level in patients with type 2 diabetes mellitus: a case-control study and meta-analysis. Journal of Diabetes 8:56–62.
  • Zhang LJ, Xie Q, Tang CS, Zhang AH. 2017. Expressions of irisin and urotensin II and their relationships with blood pressure in patients with preeclampsia. Clinical Experimental Hypertension (New york, 1993) 39:460–467.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.